Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer.

MLA

De Cobelli, Ottavio, et al. “Urotensin II Receptor on Preoperative Biopsy Is Associated with Upstaging and Upgrading in Prostate Cancer.” Future Oncology (London, England), vol. 11, no. 22, Nov. 2015, pp. 3091–98. EBSCOhost, https://doi.org/10.2217/fon.15.249.

APA

De Cobelli, O., Buonerba, C., Terracciano, D., Bottero, D., Lucarelli, G., Bove, P., Altieri, V., Coman, I., Perdonà, S., Facchini, G., Berretta, M., Di Lorenzo, G., Grieco, P., Novellino, E., Franco, R., Caraglia, M., Manini, C., Mirone, V., De Placido, S., … Ferro, M. (2015). Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer. Future Oncology (London, England), 11(22), 3091–3098. https://doi.org/10.2217/fon.15.249

Chicago

De Cobelli, Ottavio, Carlo Buonerba, Daniela Terracciano, Danilo Bottero, Giuseppe Lucarelli, Pierluigi Bove, Vincenzo Altieri, et al. 2015. “Urotensin II Receptor on Preoperative Biopsy Is Associated with Upstaging and Upgrading in Prostate Cancer.” Future Oncology (London, England) 11 (22): 3091–98. doi:10.2217/fon.15.249.